Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary: an annealing control primer system and immunohistochemical study
References (25)
- et al.
Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes
Mol Cell Endocrinol
(2003) - et al.
Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain
J Biol Chem
(1993) - et al.
The secreted tumor-associated antigen 90K is a potent immune stimulator
J Biol Chem
(1994) - et al.
Galectin-3 stimulates cell proliferation
Exp Cell Res
(1998) - et al.
Galectin-3 induces endothelial cell morphogenesis and angiogenesis
Am J Pathol
(2000) - et al.
Galectins. Structure and function of a large family of animal lectins
J Biol Chem
(1994) - et al.
Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas
Eur J Cancer
(1994) - et al.
Cancer statistics, 2007
CA Cancer J Clin
(2007) - et al.
Mucinous ovarian cancer
Int J Gynecol Cancer
(2008) - et al.
Heterogeneity of ovarian cancer: relationships among histological group, stage of disease, tumor markers, patient characteristics, and survival
Cancer Invest
(2002)
Annealing control primer system for improving specificity of PCR amplification
Biotechniques
(2003)
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer
Cancer Res
(1986)
Cited by (13)
The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review)
2022, Molecular Medicine ReportsThe role of galectins in tumor progression, treatment and prognosis of gynecological cancers
2018, Journal of CancerGalectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
2018, Cancer Management and Research
Copyright © 2009 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.